24398

544210

EMCURE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

EMCURE PHARMACEUTICALS L Share Price Today

EMCURE PHARMACEUTICALS L is currently trading at ₹1733, up by ₹27.4 from the previous close. The stock touched an intraday high of ₹1760.00 and a low of ₹1710.00 during the latest trading session. Over the past one year, EMCURE PHARMACEUTICALS L has delivered a return of 27.87%, while the stock has gained 0.04% in the last one month.

EMCURE PHARMACEUTICALS L performance

Today’s low Today’s high
₹ 1710.00 ₹ 1760.00
₹ 1732.80
52 week low 52 week high
₹ 1228.90 ₹ 1830.00
₹ 1732.80
Open Price ₹ 1710.00
Prev. Close ₹ 1705.60
Volume (Shares) 80667.00
Total traded value ₹ 1397.79
Upper Circuit ₹ 1876.10
Lower Circuit ₹ 1535.10
info

Investment Returns

Over 1 Month 0.04% Over 3 Months 16.95% Over 6 Months 22.23% Over 1 Year 27.87%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

EMCURE PHARMACEUTICALS L fundamentals


  • Market cap (Cr) 32,864.20
  • P/E Ratio (TTM) 44.10
  • Beta 0.47
  • Book Value / share 195.64
  • Return on equity 12.79%
  • EPS (TTM) 39.64
  • Dividend yield 0.21%
  • Net profit/quarter (Cr) 233.70
info icon alternate text
  • Market cap (Cr) 32,847.10
  • P/E Ratio (TTM) 44.10
  • Beta 0.38
  • Book Value / share 195.64
  • Return on equity 12.79%
  • EPS (TTM) 39.64
  • Dividend yield 0.21%
  • Net profit/quarter (Cr) 233.70
info icon alternate text

EMCURE PHARMACEUTICALS L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 1467.70
Operating Expense 1195.95
Net Profit 233.70
Net Profit Margin (%) 15.92
Earnings Per Share (EPS) 12.33
EBITDA 406.18
Effective Tax Rate (%) 23.69
Particulars DEC 2025 (Values in Cr)
Revenue 1418.31
Operating Expense 1213.09
Net Profit 258.85
Net Profit Margin (%) 18.25
Earnings Per Share (EPS) 13.65
EBITDA 409.65
Effective Tax Rate (%) 17.65
Particulars SEP 2025 (Values in Cr)
Revenue 1260.60
Operating Expense 1125.46
Net Profit 117.62
Net Profit Margin (%) 9.33
Earnings Per Share (EPS) 6.21
EBITDA 247.34
Effective Tax Rate (%) 25.50
Particulars JUN 2025 (Values in Cr)
Revenue 1096.57
Operating Expense 948.93
Net Profit 122.79
Net Profit Margin (%) 11.19
Earnings Per Share (EPS) 6.48
EBITDA 246.02
Effective Tax Rate (%) 25.88
Particulars MAR 2025 (Values in Cr)
Revenue 1278.19
Operating Expense 1114.53
Net Profit 139.56
Net Profit Margin (%) 10.91
Earnings Per Share (EPS) 7.37
EBITDA 267.03
Effective Tax Rate (%) 24.99
Particulars MAR 2026 (Values in Cr)
Revenue 5243.19
Operating Expense 4483.44
Net Profit 732.96
Net Profit Margin (%) 13.97
Earnings Per Share (EPS) 38.67
EBITDA 1309.19
Effective Tax Rate (%) 22.37
Particulars MAR 2025 (Values in Cr)
Revenue 4381.92
Operating Expense 4073.02
Net Profit 317.13
Net Profit Margin (%) 7.23
Earnings Per Share (EPS) 16.95
EBITDA 765.64
Effective Tax Rate (%) 25.85
Particulars MAR 2024 (Values in Cr)
Revenue 3497.66
Operating Expense 3426.68
Net Profit 160.83
Net Profit Margin (%) 4.59
Earnings Per Share (EPS) 8.89
EBITDA 570.83
Effective Tax Rate (%) 19.54
Particulars MAR 2023 (Values in Cr)
Revenue 3107.09
Operating Expense 3013.95
Net Profit 160.06
Net Profit Margin (%) 5.15
Earnings Per Share (EPS) 9.07
EBITDA 557.69
Effective Tax Rate (%) 24.62
Particulars MAR 2022 (Values in Cr)
Revenue 3387.24
Operating Expense 2903.50
Net Profit 446.81
Net Profit Margin (%) 13.19
Earnings Per Share (EPS) 24.66
EBITDA 927.34
Effective Tax Rate (%) 27.51
Particulars MAR 2025 (Values in Cr)
Book Value / Share 234.65
ROE % 19.12
ROCE % 20.01
Total Debt to Total Equity 0.45
EBITDA Margin 19.39
Particulars MAR 2024 (Values in Cr)
Book Value / Share 162.97
ROE % 19.35
ROCE % 18.23
Total Debt to Total Equity 0.86
EBITDA Margin 19.18
Particulars MAR 2023 (Values in Cr)
Book Value / Share 138.30
ROE % 25.03
ROCE % 20.75
Total Debt to Total Equity 1.01
EBITDA Margin 20.40
Particulars MAR 2022 (Values in Cr)
Book Value / Share 109.90
ROE % 32.98
ROCE % 25.00
Total Debt to Total Equity 1.06
EBITDA Margin 23.80
Particulars MAR 2021 (Values in Cr)
Book Value / Share 125.68
ROE % 20.14
ROCE % 21.08
Total Debt to Total Equity 1.11
EBITDA Margin 24.83
Particulars MAR 2025 (Values in Cr)
Book Value / Share 159.61
ROE % 12.79
ROCE % 14.36
Total Debt to Total Equity 0.49
EBITDA Margin 17.47
Particulars MAR 2024 (Values in Cr)
Book Value / Share 106.82
ROE % 8.52
ROCE % 10.08
Total Debt to Total Equity 0.89
EBITDA Margin 16.32
Particulars MAR 2023 (Values in Cr)
Book Value / Share 101.84
ROE % 9.01
ROCE % 10.69
Total Debt to Total Equity 0.94
EBITDA Margin 17.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 94.69
ROE % 22.26
ROCE % 20.50
Total Debt to Total Equity 0.79
EBITDA Margin 27.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 127.27
ROE % 19.95
ROCE % 18.88
Total Debt to Total Equity 0.69
EBITDA Margin 26.54
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 165.29
Total Assets 8232.72
Total Liabilities 8232.72
Total Equity 4641.55
Share Outstanding 18
Price to Book Ratio 6.72
Return on Assets (%) 8.27
Return on Capital (%) 12.68
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 232.40
Total Assets 7806.16
Total Liabilities 7806.16
Total Equity 3121.76
Share Outstanding 18
Price to Book Ratio 0.00
Return on Assets (%) 6.38
Return on Capital (%) 9.56
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 458.25
Total Assets 6672.53
Total Liabilities 6672.53
Total Equity 2649.66
Share Outstanding 18
Price to Book Ratio 0.00
Return on Assets (%) 7.97
Return on Capital (%) 10.98
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 313.29
Total Assets 6063.46
Total Liabilities 6063.46
Total Equity 2114.14
Share Outstanding 18
Price to Book Ratio 0.00
Return on Assets (%) 10.92
Return on Capital (%) 15.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 523.53
Total Assets 6807.39
Total Liabilities 6807.39
Total Equity 2368.01
Share Outstanding 18
Price to Book Ratio 0.00
Return on Assets (%) 6.14
Return on Capital (%) 9.68
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 13.79
Total Assets 5416.11
Total Liabilities 5416.11
Total Equity 3024.36
Share Outstanding 18
Price to Book Ratio 6.72
Return on Assets (%) 5.85
Return on Capital (%) 8.62
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 32.12
Total Assets 4756.93
Total Liabilities 4756.93
Total Equity 1935.09
Share Outstanding 18
Price to Book Ratio 0.00
Return on Assets (%) 3.38
Return on Capital (%) 4.8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 141.01
Total Assets 4615.84
Total Liabilities 4615.84
Total Equity 1841.86
Share Outstanding 18
Price to Book Ratio 0.00
Return on Assets (%) 3.46
Return on Capital (%) 4.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 47.88
Total Assets 4323.18
Total Liabilities 4323.18
Total Equity 1712.52
Share Outstanding 18
Price to Book Ratio 0.00
Return on Assets (%) 10.33
Return on Capital (%) 13.58
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 260.72
Total Assets 4863.19
Total Liabilities 4863.19
Total Equity 2301.77
Share Outstanding 18
Price to Book Ratio 0.00
Return on Assets (%) 8.64
Return on Capital (%) 11.66
Particulars MAR 2025 (Values in Cr)
Net Income 971.34
Cash from Operations 1098.56
Cash from Investing -94.00
Cash from Financing -813.95
Net change in Cash -56.25
Free Cash Flow 1320.33
Particulars MAR 2024 (Values in Cr)
Net Income 727.22
Cash from Operations 1320.89
Cash from Investing -712.51
Cash from Financing -164.20
Net change in Cash 220.52
Free Cash Flow 1596.66
Particulars MAR 2023 (Values in Cr)
Net Income 747.21
Cash from Operations 947.32
Cash from Investing -467.68
Cash from Financing -145.39
Net change in Cash 133.77
Free Cash Flow 1337.92
Particulars MAR 2022 (Values in Cr)
Net Income 972.54
Cash from Operations 1079.38
Cash from Investing -788.79
Cash from Financing -151.85
Net change in Cash -172.43
Free Cash Flow 1482.58
Particulars MAR 2021 (Values in Cr)
Net Income 657.32
Cash from Operations 904.86
Cash from Investing -251.84
Cash from Financing -188.90
Net change in Cash 259.06
Free Cash Flow 1050.53
Particulars MAR 2025 (Values in Cr)
Net Income 427.71
Cash from Operations 624.39
Cash from Investing -435.61
Cash from Financing -49.24
Net change in Cash 73.42
Free Cash Flow 820.54
Particulars MAR 2024 (Values in Cr)
Net Income 199.91
Cash from Operations 651.83
Cash from Investing -171.07
Cash from Financing -287.74
Net change in Cash 126.14
Free Cash Flow 901.09
Particulars MAR 2023 (Values in Cr)
Net Income 212.33
Cash from Operations 589.91
Cash from Investing -270.43
Cash from Financing -54.51
Net change in Cash 180.42
Free Cash Flow 861.57
Particulars MAR 2022 (Values in Cr)
Net Income 616.42
Cash from Operations 598.38
Cash from Investing -188.99
Cash from Financing -342.96
Net change in Cash -309.06
Free Cash Flow 772.45
Particulars MAR 2021 (Values in Cr)
Net Income 557.44
Cash from Operations 888.54
Cash from Investing -831.16
Cash from Financing 30.97
Net change in Cash -25.32
Free Cash Flow 988.63
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.39 13.80 1.61 255.88 23.12 38.85
BLISS GVS PHARMA LTD. 439.70 35.69 3.90 4663.29 118.35 462.70
CIPLA LTD. 1381.50 29.32 3.24 111603.83 1165.55 1672.20
FERMENTA BIOTECH LTD. 328.70 14.50 2.37 967.40 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.39 23.35 4.30 255.88 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 553.70 24.82 4.32 1600.78 490.00 789.95
ASTRAZENECA PHARMA IND LT 8425.15 110.03 24.13 21062.88 7630.00 10557.00
BLISS GVS PHARMA LTD. 439.70 47.43 4.03 4663.29 118.35 462.70

EMCURE PHARMACEUTICALS L shareholding pattern

Holding
12.68%
77.86%
3.35%
6.09%
0.04%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

EMCURE PHARMACEUTICALS L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1732.80 1.59 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 1717.10
  • 26 Days 1703.90
  • 10 Days 1718.80
  • 50 Days 1667.20
  • 12 Days 1718.10
  • 100 Days 1600.00
  • 20 Days 1711.40
  • 200 Days 1518.40
1708.47 PIVOT
First Support 1678.13 First Resistance 1735.93 Second Support 1650.67 Second Resistance 1766.27 Third Support 1620.33 Third Resistance 1793.73
RSI 50.42 ADX 47.83 MACD 14.24 Williams % R -74.44 Commodity Channel Index (CCI) -51.75
Date 2026-06-15 Week 92047.00 Same Day 140171.00 Month 72373.00
1 Year 0.47 3 Year 0.86
Over 1 Month
0.04% down
Over 1 Year
27.87% down
Over 3 Months
16.95% down
Over 3 Years
0.00% down
Over 6 Months
22.23% down
Over 5 Years
0.00% down

EMCURE PHARMACEUTICALS L Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
14 Aug 2025 3.0 Final 14 Aug 2025 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
14 Aug 2025 3.0 Final 14 Aug 2025 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Emcure Pharmaceuticals Ltd?

Answer Field

Emcure Pharmaceuticals Ltd share price is for NSE ₹ 1,733.00 & for BSE ₹ 1,731.70 as on Jun 16 2026 03:29 PM.

What is the Market Cap of Emcure Pharmaceuticals Ltd Share?

Answer Field

The market cap of Emcure Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 16 2026 03:29 PM.

What is the 52 Week High and Low of Emcure Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Emcure Pharmaceuticals Ltd for NSE is ₹ 1,830.00 and ₹ 1,228.90 and for BSE is ₹ 1,830.35 and ₹ 1,230.00.

What is 1 year return for Emcure Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 27.87%.

What is the P/E Ratio of Emcure Pharmaceuticals Ltd Share?

Answer Field

As on Jun 16 2026 03:29 PM the price-to-earnings (PE) ratio for Emcure Pharmaceuticals Ltd share is 44.10.

What is the PB ratio of Emcure Pharmaceuticals Ltd Share?

Answer Field

As on Jun 16 2026 03:29 PM, the price-to-book (PB) ratio for Emcure Pharmaceuticals Ltd share is 195.64.

How to Buy Emcure Pharmaceuticals Ltd Share?

Answer Field

You can trade in Emcure Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Emcure Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Emcure Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Emcure Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|